Description
The HI-PEITHO mobile application is a reference tool intended to assist Boston Scientific authorized clinical trial centers participating in the HI-PEITHO clinical trial. This app is used to support the preliminary assessment tasks related to the trial and includes the following features:
- Inclusion / Exclusion Criteria
- NEWS Score Calculator Questionnaire
- Trial Informational Pages
Hide
Show More...
- Inclusion / Exclusion Criteria
- NEWS Score Calculator Questionnaire
- Trial Informational Pages
Screenshots
HI-PEITHO FAQ
-
Is HI-PEITHO free?
Yes, HI-PEITHO is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is HI-PEITHO legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does HI-PEITHO cost?
HI-PEITHO is free.
-
What is HI-PEITHO revenue?
To get estimated revenue of HI-PEITHO app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Switzerland yet.
Ratings History
HI-PEITHO Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
HI-PEITHO Installs
Last 30 days
HI-PEITHO Revenue
Last 30 daysHI-PEITHO Revenue and Downloads
Gain valuable insights into HI-PEITHO performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
Boston Scientific
- Languages
- English
- Recent release
- 1.0.5 (2 years ago )
- Released on
- Apr 15, 2022 (2 years ago )
- Also available in
- Austria, Switzerland, Germany, France, United Kingdom, Ireland, Poland, United States
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.